| |
| |
|
| Insider
Information: |
Dubow Adam |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,362 |
|
|
Indirect Shares
|
972 |
|
|
| Direct
Value |
$617,898 |
|
|
|
Indirect Value
|
$43,594 |
|
|
| Total
Shares |
31,334 |
|
|
| Total
Value |
$661,493 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP,ChiefCompliance&Et... |
2021-07-30 |
13,777 |
2021-07-30 |
972 |
Premium* |
|
|
Day One Biopharmaceuticals, Inc. |
DAWN |
|
2024-02-16 |
16,585 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DAWN |
Day One Biopharmaceutical... |
GENERAL COUNSEL |
• – – |
2024-02-16 |
4 |
S |
$15.25 |
$49,434 |
D/D |
(3,242) |
16,585 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
GENERAL COUNSEL |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,399 |
19,827 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
General Counsel |
• – – |
2023-11-16 |
4 |
S |
$11.69 |
$62,109 |
D/D |
(5,313) |
11,428 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
General Counsel |
• – – |
2023-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,600 |
16,741 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
General CounselOfficer |
• – – |
2023-11-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,141 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2021-07-30 |
4 |
S |
$67.90 |
$167,441 |
D/D |
(2,466) |
13,777 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2021-05-05 |
4 |
S |
$64.21 |
$200,271 |
D/D |
(3,119) |
16,243 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2021-03-10 |
4 |
D |
$60.93 |
$116,376 |
D/D |
(1,910) |
19,362 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
718 |
20,297 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,404 |
19,811 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(36) |
15,895 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-11-24 |
4 |
S |
$63.39 |
$57,051 |
D/D |
(900) |
15,186 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-05-22 |
4 |
S |
$61.01 |
$195,232 |
D/D |
(3,200) |
16,086 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$116,150 |
D/D |
(2,005) |
19,286 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
561 |
20,363 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,007 |
20,091 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(26) |
16,697 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Compliance & Ethics Offi |
• – – |
2019-12-05 |
4 |
S |
$58.81 |
$102,329 |
D/D |
(1,740) |
15,749 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Compliance & Ethics Offi |
• – – |
2019-03-10 |
4 |
D |
$51.39 |
$60,743 |
D/D |
(1,182) |
17,489 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Compliance & Ethics Offi |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,735 |
18,240 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Compliance & Ethics Offi |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(286) |
16,153 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Compliance & Ethics Offi |
• – – |
2018-09-03 |
4 |
D |
$60.55 |
$16,530 |
D/D |
(273) |
15,222 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Compliance & Ethics Offi |
• – – |
2018-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
797 |
15,495 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
